grepcent public filings, reorganized for comparison

KYBELLA — FDA application NDA206333

Application NDA206333 · type NDA · FDA status: approved · original approval 2015-04-29

Listed sponsor: ABBVIE · ABBV company profile · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

FDA application facts

ProductFDA-listed trade nameActive ingredientDosage formRouteStrengthMarketing statusTE codeRLD
001KYBELLADEOXYCHOLIC ACIDSOLUTIONSUBCUTANEOUS20MG/2ML (10MG/ML)PrescriptionAPYes

Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.

Orange Book patent and exclusivity listings

ListingProductDescriptive dateFlags/code
Patent 7622130001listed patent expiry date: 2027-12-10U-1690
Patent 7754230001listed patent expiry date: 2027-12-10U-1690
Patent 8461140001listed patent expiry date: 2028-02-21drug product
Patent 8546367001listed patent expiry date: 2028-02-21drug product, U-1690
Patent 8883770001listed patent expiry date: 2028-02-21drug product
Patent 9522155001listed patent expiry date: 2028-02-21drug product, U-1940
Patent 9636349001listed patent expiry date: 2028-02-21U-1940
Patent 9949986001listed patent expiry date: 2028-02-21U-1940
Patent 8242294001listed patent expiry date: 2028-05-16drug substance
Patent 10500214001listed patent expiry date: 2030-03-02drug product
Patent 8101593001listed patent expiry date: 2030-03-02drug product
Patent 8367649001listed patent expiry date: 2030-03-02drug product
Patent 8653058001listed patent expiry date: 2030-03-02drug product
Patent 12161653001listed patent expiry date: 2032-02-17U-1940
NDA206333 FDA listing dates. Source: Drugs@FDA and FDA Orange Book.NDA206333 FDA listing dates. Source: Drugs@FDA and FDA Orange Book.NDA206333 FDA listing datesDescriptive regulatory dates only; no relationship to revenue or future sales is stated or implied.Source: Drugs@FDA and FDA Orange Book.Listed dateDated listing marker0.001.002.002015-04-291.002027-12-101.002028-02-211.002028-05-161.002030-03-021.002032-02-171.00

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

Compound cross-links

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

Related pages

Sponsor company · FDA-approved application index

Peer clusters: Large-cap biopharma

Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.